TrialJournal of clinical oncology : official journal of the American Society of Clinical Oncology2025

Adjuvant Nivolumab in High-Risk Muscle-Invasive Urothelial Carcinoma: Expanded Efficacy From CheckMate 274.

Matthew D Galsky et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.